Warren is a highly accomplished enterprise leader with extensive global experience in the life science and diagnostic sectors, who most recently served as President of Americas at Ortho Clinical Diagnostics (now QuidelOrtho).

Jeff has over 32 years of finance experience in the healthcare services industry, having gained a well-rounded background from serving in finance roles at public companies of different sizes and at different growth stages in their life cycle.

Chris joins NeoGenomics from Ortho Clinical Diagnostics (now QuidelOrtho), where he served as Chairman and CEO from 2019 to 2022. During his leadership, Ortho Clinical raised $1.45 billion in funding in a Q1 2021 initial public offering and achieved accelerated revenue growth from 1% annually to low double-digit levels, while simultaneously improving profitability. Chris also successfully guided the company through a combination with Quidel that closed in May 2022.